T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

Multiple myeloma — cancer of the white blood cells known as plasma cells — can cause a vast spectrum of symptoms as it progresses. But multiple myeloma often has no outward signs in its early ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of ...

Based on histopathologic evaluation, tumors cells were large and round often growing in rows in a delicate stroma. They had large, round vesicular nuclei with single prominent nucleoli. The cytoplasm ...

The dog’s limb was spared because the shelter found an Australian company called Virbac, had an approved drug sold as Stelfonta. it does wonders against mast cell tumors in dogs.

The results mark a key step in the realization of engineered plasma cells (ePCs) as therapies to treat cancer, autoimmune disorders, and protein deficiency disorders.

But what happens to cancer cells after they die? Typically, the slain tumor cells are recycled in the same way that any other dead cell in the body would be.

Plasmapheresis is an uncommon treatment that can be used to manage something called myeloma kidney, a type of kidney failure that affects many people with multiple myeloma. It separates out plasma ...

Plasma cell neoplasms are a group of diseases – some cancerous – where certain blood cells don’t work like they should. Learn the symptoms, tests you might need, and options for treatment.

Mast cell tumors are the most common malignant tumor in dogs. Here’s what you need to know about symptoms and treatment options.

Trial launched to test CAR T-cell therapy in dogs diagnosed with solid tumors Gates Institute member Steve Dow, DVM, is the principal investigator of Colorado State University’s first clinical ...

Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage ...